Luminex To Unveil New Sample-to-answer System For Infectious Disease Testing

(RTTNews) - Luminex Corp. (LMNX) said it would unveil its new sample-to-answer system for infectious disease testing, ARIES at the European Congress of Clinical Microbiology and Infectious Diseases or ECCMID.

ARIES' scalable throughput, easy to use design, and networked data management software would deliver rapid results with a simple workflow, the company said.

The five assay launch menu targeted for the ARIES system includes Flu A/B and RSV, HSV 1&2, Norovirus and Clostridium difficile. Future menu items will be announced at a later date.

Russell Bradley, senior vice president, corporate development and global marketing, said, "ARIES will revolutionize molecular diagnostic testing with a system that integrates seamlessly into the laboratory. Enabling laboratories to produce faster results, and better manage their QC and compliance requirements can increase service levels to hospitals and doctors for improved patient care."